Patrick S. Ward

21.5k citations

26 papers · 12.4k indexed · 6 hit papers · h-index 20

Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism 13
- Cancer Genomics and Diagnostics 3
Genetics top 0.1%
- Glioma Diagnosis and Treatment 6
Hematology top 0.5%
- Acute Myeloid Leukemia Research 4
Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 7
- Histone Deacetylase Inhibitors Research 3
Biochemistry top 0.5%
Surgery
- Pancreatic function and diabetes 3
Radiology, Nuclear Medicine and Imaging
- Medical Imaging Techniques and Applications 2

Co-authors: Craig B. Thompson Joshua D. Rabinowitz Ross L. Levine Valeria R. Fantin Shinsan M. Su Bryson D. Bennett Justin R. Cross Chao Lü
Cited by: Cancer Research Genetics Hematology
Journals: Nature (4 papers)Genes & Development (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Patrick S. Ward

24 papers receiving 12.3k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2012 Cancer Cell
2012 Nature
2012 Nature
2011 Proceedings of the National Academy of Sciences
2010 Cancer Cell
2009 Nature

Peers

Countries citing papers authored by Patrick S. Ward

Since Specialization

Citations

This map shows the geographic impact of Patrick S. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick S. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick S. Ward more than expected).

Fields of papers citing papers by Patrick S. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick S. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick S. Ward. The network helps show where Patrick S. Ward may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick S. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick S. Ward Line = papers co-authored together Patrick S. Ward links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Training-Load Management Ambiguities and Weak Logic: Creating Potential Consequences in Sport Training and Performance International Journal of Sports Physiology and Performance ·Stephen West,Ian Shrier,Franco M. Impellizzeri,Jo Clubb,Patrick S. Ward,Christophe Machal	2024	4
2	Discovery and molecular basis of subtype-selective cyclophilin inhibitors Nature Chemical Biology ·Yael Baruch,杨敏福,Manish Thakur,Patrick S. Ward,H. Niedermueller,Jason R. Birk,Alix I Chan,Dmitry L. Usanov,Vamsi K. Mootha,Markus A. Seeliger,David R. Liu	2022	22
3	The impact of chitosan on the early metabolomic response of wheat to infection by Fusarium graminearum BMC Plant Biology ·Jean Grondin,Nadia Lamari,Carl K.‐Y. Ng,Patrick S. Ward,Fiona M. Doohan	2022	18
4	Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate Journal of Biological Chemistry ·Joseph P. Dexter,Patrick S. Ward,Tathagata Dasgupta,Aaron M. Hosios,Jeremy Gunawardena,Matthew G. Vander Heiden	2018	13
5	Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia Cancer Discovery ·Alan H. Shih,Cem Meydan,Kaitlyn Shank,Francine E. Garrett-Bakelman,Patrick S. Ward,Andrew M. Intlekofer,Abbas Nazir,Eytan M. Stein,Kristina M. Knapp,Jacob L. Glass,Jeremy Travins,Roby Juahta Ketaren,Camelia Gliser,Christopher E. Mason,Katharine Yen,Craig B. Thompson,Ari Melnick,Ross L. Levine	2017	71
6	SnapShot: Cancer Metabolism Pathways Cell Metabolism ·Lydia W.S. Finley,Ji Zhang,Jiangbin Ye,Patrick S. Ward,Craig B. Thompson	2013	38
7	The common feature of cancer-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to the oncometabolite 2-hydroxyglutarate Science Advances ·Patrick S. Ward	2013	0
8	Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition Genes & Development ·Chong Chen,Yu Liu,Chao Lü,Justin R. Cross,John P. Morris,Aditya Shroff,Patrick S. Ward,James E. Bradner,Craig B. Thompson,Scott W. Lowe	2013	151
9	Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipatebreakdown → Cancer Cell ·Patrick S. Ward,Craig B. Thompson	2012	2452
10	Signaling in Control of Cell Growth and Metabolism Cold Spring Harbor Perspectives in Biology ·Patrick S. Ward,Craig B. Thompson	2012	227
11	IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypebreakdown → Nature ·Şevin Turcan,Daniel Rohle,Anuj Goenka,Logan A. Walsh,Fang Fang,Emrullah Yilmaz,Carl Campos,Armida W. M. Fabius,Chao Lü,Patrick S. Ward,Craig B. Thompson,Andrew Kaufman,Olga A. Guryanova,Ross L. Levine,Adriana Heguy,Agnès Viale,Luc G.T. Morris,Jason T. Huse,Ingo K. Mellinghoff,Timothy A. Chan	2012	1382
12	The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization Journal of Biological Chemistry ·Patrick S. Ward,Chao Lü,Justin R. Cross,Omar Abdel‐Wahab,Ross L. Levine,Gary K. Schwartz,Craig B. Thompson	2012	121
13	IDH mutation impairs histone demethylation and results in a block to cell differentiationbreakdown → Nature ·Chao Lü,Patrick S. Ward,Gurpreet S. Kapoor,Dan Rohle,Şevin Turcan,Omar Abdel‐Wahab,Christopher R. Edwards,Raya Khanin,María E. Figueroa,Ari Melnick,Kathryn E. Wellen,Donald M. O’Rourke,Shelley L. Berger,Timothy A. Chan,Ross L. Levine,Ingo K. Mellinghoff,Craig B. Thompson	2012	1453
14	Identification of additional IDH mutations associated with oncometabolite R(−)-2-hydroxyglutarate production Oncogene ·Patrick S. Ward,Justin R. Cross,Chao Lü,Oliver Weigert,Boulahssass Rabia,Ross L. Levine,David M. Weinstock,Kim A. Sharp,Craig B. Thompson	2011	150
15	Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viabilitybreakdown → Proceedings of the National Academy of Sciences ·David R. Wise,Patrick S. Ward,Jessica E.S. Shay,Justin R. Cross,Joshua J. Gruber,Uma M. Sachdeva,Jesse M. Platt,Raymond G. Dematteo,M. Celeste Simon,Craig B. Thompson	2011	791
16	The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutaratebreakdown → Cancer Cell ·Patrick S. Ward,Jay Patel,David R. Wise,Omar Abdel‐Wahab,Bryson D. Bennett,Hilary A. Coller,Justin R. Cross,Valeria R. Fantin,Cyrus V. Hedvat,Alexander E. Perl,Joshua D. Rabinowitz,Martin Carroll,Shinsan M. Su,Kim A. Sharp,Ross L. Levine,Craig B. Thompson	2010	1483
17	Abstract 33: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Cancer Research ·Valeria R. Fantin,Lenny Dang,David W. White,Stefan Größ,Mark Bittinger,Edward M. Driggers,Hyun Gyung Jang,Shengfang Jin,Marie C. Keenan,Kevin M. Marks,Katharine Yen,Patrick S. Ward,Robert M. Prins,Linda M. Liau,Bryson D. Bennett,Joshua D. Rabinowitz,Lewis C. Cantley,Craig B. Thompson,Matthew G. Vander Heiden,Shinsan M. Su	2010	4
18	Cancer-associated IDH1 mutations produce 2-hydroxyglutaratebreakdown → Nature ·Lenny Dang,David W. White,Stefan Größ,Bryson D. Bennett,Mark Bittinger,Edward M. Driggers,Valeria R. Fantin,Hyun Gyung Jang,Shengfang Jin,Marie C. Keenan,Kevin M. Marks,Robert M. Prins,Patrick S. Ward,Katharine Yen,Linda M. Liau,Joshua D. Rabinowitz,Lewis C. Cantley,Craig B. Thompson,Matthew G. Vander Heiden,Shinsan M. Su	2009	3067
19	Structural and Biochemical Basis for Polyamine Binding to the Tp0655 Lipoprotein of Treponema pallidum: Putative Role for Tp0655 (TpPotD) as a Polyamine Receptor Journal of Molecular Biology ·Mischa Machius,Chad A. Brautigam,Diana R. Tomchick,Patrick S. Ward,Zbyszek Otwinowski,Jon S. Blevins,Ranjit K. Deka,Michael V. Norgard	2007	32
20	Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line Diabetologia ·Anna K. Simpson,Patrick S. Ward,Kai Yuen Wong,Grace Collord,Abdella M. Habib,Frank Reimann,Fiona M. Gribble	2007	71

About Patrick S. Ward

Patrick S. Ward is a scholar working on Cancer Research, Genetics, Hematology, Molecular Biology and Orthopedics and Sports Medicine, having authored 26 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Epigenetics and DNA Methylation (7 papers), Glioma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers), Histone Deacetylase Inhibitors Research (3 papers), Cancer Genomics and Diagnostics (3 papers), Pancreatic function and diabetes (3 papers) and Medical Imaging Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (6.6k citations), Genetics (3.4k citations), Hematology (1.5k citations), Molecular Biology (8.4k citations) and Biochemistry (532 citations). Patrick S. Ward has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Craig B. Thompson, Joshua D. Rabinowitz, Ross L. Levine, Valeria R. Fantin, Shinsan M. Su, Bryson D. Bennett, Justin R. Cross, Chao Lü, Omar Abdel‐Wahab and Katharine Yen. Their work appears in journals such as Nature, Genes & Development, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact